27.33
+1.30%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nanjing Well Pharmaceutical Group Co
Its shares trade on Shanghai under the ticker 603351.SS. It has been listed since 30 January 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.34bn and net income of CN¥151.0m. At that date it held total assets of CN¥2.59bn and shareholders' equity of CN¥1.80bn.
Nanjing Well Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2019-01-30. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The firm distributes its products primarily in domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 30 Jan 2019
- Employees
- 658
- Website
- well-js.com ↗
Leadership
Pay as last reported
- Ren Rong WuChairman & General Manager, since 2000
- Qun Song TangChief Financial Officer & Board Secretary, since 2000
- Zheng Song GaoDirector, Chief Engineer & Deputy General Manager, since 2000
- Rong Wen WuChairman-Supervisory Board, since 2000
- You Hong LiMember-Supervisory Board & Safety Director, since 2007
- Li Ping Fan, MBA, CPADirector & Deputy Chief Engineer, since 2005
- Xin Guo ChenDirector & Deputy General Manager, since 2000
- Rong Wen WuChairman-Supervisory Board, since 2017
- Ren Rong WuChairman & General Manager, since 2017
- Zheng Song GaoDirector, Chief Engineer & Deputy General Manager, since 2017
- Ru JiaIndependent Director, since 2017
- Yan Wei Yang, CPAIndependent Director, since 2017
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Nanjing Well Pharmaceutical Group employs 658 skilled workers in Nanjing, China.
- The company produces pharmaceutical excipients and synthetic lubricating base oils for domestic markets.
- Nanjing Well Pharmaceutical's main products include pharmaceutical auxiliary materials and pesticide additives.
Weaknesses
- The company's domestic market focus limits international expansion opportunities.
- Nanjing Well Pharmaceutical has no international presence beyond China's borders.
- The firm relies solely on the domestic market for product distribution.
Opportunities
- Expanding into international markets could increase Nanjing Well Pharmaceutical's market reach.
- Growing demand for pharmaceutical excipients presents new business opportunities.
- Increasing global demand for synthetic lubricating base oils offers potential growth.
Threats
- Competition from domestic chemical manufacturers poses a threat to market share.
- Regulatory changes in China's chemical industry could impact operations.
- Economic downturns in China may reduce demand for pharmaceutical products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.